Pharmaceutical

WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration

February 22, 2018

Agreement follows the recent opening of WuXi STA’s oligonucleotide R&D labs in China and the USA SHANGHAI, 22 Feb 2018: STA Pharmaceutical Co., Ltd. (STA), a WuXi AppTec group company and the leading open-access capability and technology platform for small molecule pharmaceutical development and manufacturing, and Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery […]

Bioclinica Delivers Individual Case Safety Report (ICSR) Processing with Quality and Consistency While Crossing One Million Case Milestone in 2017

February 22, 2018

Quality and value in Bioclinica ICSR outsourcing enable drug safety operations to meet global regulatory requirements for safety monitoring of medicines PRINCETON, NJ– Bioclinica®, the world-leading provider of scientific- and technology-enabled solutions for clinical research, today announces its ICSR team delivered quality and consistency in Individual Case Safety Report (ICSR) processing while crossing the one […]

DrugDev Introduces Consent Engineering, the Clinical Trials Industry’s First Truly SaaS Solution for Creating, Managing and Automating Informed Patient Consent In-House

February 21, 2018

Simple yet robust technology tools are primed to change completely the way pharmaceutical companies and CROs develop, implement and track patient consent across global clinical trial sites Today at the 2018 SCOPE Summit for Clinical Operations Executives, DrugDev (an IQVIA company) unveiled the industry’s first truly SaaS solution for electronic patient informed consent. Consent Engineering, […]

Amneal Introduces Memantine Hydrochloride Extended-Release Capsules, Generic for Namenda XR®

February 21, 2018

Amneal Pharmaceuticals has launched memantine hydrochloride extended-release capsules, the company’s AB-rated equivalent for Namenda XR®, in 7 mg, 14 mg, 21 mg and 28 mg strengths. The product is manufactured here in the United States in the company’s recently expanded Brookhaven, New York facility. Annual U.S. sales of Namenda XR® were $929 million, according to […]

Envigo appoints Lynn Lewis as Senior Vice President of Global Sales

February 21, 2018

East Millstone, NJ, February 21, 2018 – Envigo, a leading provider of nonclinical contract research services and research models, today announced the appointment of Lynn Lewis to the position of Senior Vice President, Global Sales. She brings extensive knowledge in both science and business to the company through her successful career in pharmaceuticals and leadership roles […]

FEEDBACK